Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma
This treatment has been approved for sale to the public.
Sponsor:
GE Healthcare
Information provided by:
GE Healthcare
ClinicalTrials.gov Identifier:
NCT00730444
First received: August 5, 2008
Last updated: November 5, 2009
Last verified: November 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This treatment has been approved for sale to the public. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |